Urokinase inhibitors and uses thereof

Details Urokinase inhibitors and uses thereof Urokinase inhibitors and uses thereof

2003-10-24

2008-03-11

Padmanabhan, Sreeni (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S252100, C514S215000, C514S230500, C514S630000

Reexamination Certificate

active

07342018

ABSTRACT:
The invention relates to the use of derivatives of 3-amidinophenylalanine as urokinase inhibitors for treating malignant tumors and the formation of metastases.

REFERENCES:
patent: 5449663 (1995-09-01), Bicher
patent: 5736129 (1998-04-01), Medenica et al.
patent: 30 35 086 (1981-04-01), None
patent: 0 183 271 (1986-06-01), None
patent: WO 92/08709 (1992-03-01), None
patent: WO 95/17885 (1994-07-01), None
patent: WO 94/18185 (1994-08-01), None
patent: WO 96/05189 (1996-02-01), None
patent: WO 00/17158 (2000-03-01), None
PENTAPHARM 1998 Product Catalog.
Xing et al. Cancer Research 57, 3585-3593 (1997).
De Vita et al. Cancer Principles & Practice of Oncology, Fifth Edition. Lippincott Williams & Wilkins (1997).
Trisha Gura, Systems for Identifying New Drugs Are Often Faulty, Nov. 1997, Science, vol. 278, pp. 1041-1042.
Andreasen et al, The Urokinase-Type Plasminogen Activator System in Cancer Metastasis: A Review, 1997, Int. J. Cancer, vol. 72, pp. 1-22.
Weidle et al, Urokinase Receptor Antagonists: Novel Agents for the Treatment of Cancer, 1998, Expert Opinion on Investigational Drugs, vol. 7, No. 3, pp. 391-403.
Andeasen et al, The Urokinase-Type Plaminogen Activator System in Cancer Metastasis: A Review, 1997, Int. J. Cancer, vol. 72, pp. 1-22.
Towle et al, Inhibition of Urokinase by 4-Substituted Benzo[b]thiophene-2-carboxamidines: An Important New Class of Selective Synthetic Urokinase Inhibitor, 1993, Cancer Research, vol. 53, pp. 2553-2559.
Alonso et al, Effects of Synthetic Urokinase Inhibitors on Local Invasion and Metastasis in a Murine Mammary Tumor Model, 1996, Breast Cancer Research and Treatment, vol. 40, pp. 209-223.
Rabbani et al, Prevention of Prostate-Cancer Metastasis In Vivo by a Novel Synthetic Inhibitor of Urokinase-Type Plasminogen Activator (uPA), 1995, Int. J. Cancer, vol. 63, pp. 840-845.
Sperl et al, (4-aminomethyl)phenylguanidine Derivatives as Nonpeptidic Highly Selective Inhibitor of Human Urokinase, 2000, PNAS, vol. 97, No. 10, pp. 511305118.
Buddy et al, Anti-Tumor and Anti-Metastatic Activity of the Urokinase/Plasmin Inhibitor, WX-UK1, as Single Agent or in Combination with Epirubicin in the Rat BN-472 Mammary Carcinoma Model, 2001, Proceedings of the American Association for Cancer Research, vol. 42, Abstract No. 371.
Buddy et al, Suppression of Rat Brest Cancer Metastasis and Reduction of Primary Tumor Growth by the Small Synthetic Urokinase Inhibitor WX-UK1, 2005, Thromb Haemost, vol. 93, pp. 779-786.
Sturzebecher et al, 3-Amidinophenylalanine-Based Inhibitors of Urokinase, 1999, Bioorganic and Medicinal Chemistry Letters, vol. 9, pp. 3147-3152.
Renatus et al, Structural and Functional Analyses of Benzamidine-Based Inhibitors in Complex with Trypsin: Implications for the Inhibition of Factor Xa, tPA, and Urokinase, 1998, J. Med. Chem, vol. 41, pp. 5445-5456.
Sperl et al, The uPA/uPA Receptor System as a Target for Tumor Therapy, 2001, Drug News Perspect, vol. 14, No. 7, pp. 401-411.
Schmitt et al, Clinical Impact of the Plasminogen Activation System in Tumor Invasion and Metastasis: Prognostic Relevance and Target for Therapy, 1997, Thrombosis and Haemostasis, vol. 78, No. 1, pp. 285-296.
English Translation of Swiss Patent No. CH 689 611 A5, published Jul. 15, 1999.
English Translation of WO 00/17158 published Mar. 30, 2000.
Suerzebecher et al. Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: implications for the inhibition of factor Xa, tPA, and Urokinase, J. Med. Chem. 41:5445-5456, 1998.
PENTAPHARM Product Catalog 1998, copy attached.
PENTAPHARM Product Catalog 1997.
Onkologie May 2004, Chemotherapie.
Breastcancer.org,Hormonal Therapy, www.breastcancer.ort/tre—sys—idx.htm, Jul. 1, 2005.
National Cancer Institute, Cancer Facts, Tamoxifen: Questions and Answers, May 13, 2002.

Affiliated with

Also associated with

Rating

Urokinase inhibitors and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Urokinase inhibitors and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Urokinase inhibitors and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3980245